Alembic Pharma buys stake in US biotech RIGImmune

The biotech was founded by Dr. Anna Pyle and Dr. Akiko Iwasaki is focused on the development of RNA based therapies for viral diseases and oncology applications by targeting the innate immune target, RIG-I.

via Economictimes